Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $1.12 Million - $1.25 Million
-19,376 Reduced 83.04%
3,958 $229,000
Q2 2023

Aug 08, 2023

BUY
$63.71 - $70.74 $63,200 - $70,174
992 Added 4.44%
23,334 $1.49 Million
Q1 2023

May 04, 2023

BUY
$65.71 - $74.53 $1.25 Million - $1.41 Million
18,978 Added 564.15%
22,342 $1.55 Million
Q4 2022

Feb 07, 2023

SELL
$68.48 - $81.09 $19,105 - $22,624
-279 Reduced 7.66%
3,364 $242,000
Q3 2022

Nov 09, 2022

SELL
$0.13 - $76.84 $16 - $9,605
-125 Reduced 3.32%
3,643 $259,000
Q2 2022

Aug 08, 2022

BUY
$72.62 - $79.98 $55,263 - $60,864
761 Added 25.31%
3,768 $290,000
Q1 2022

May 03, 2022

SELL
$61.48 - $73.72 $72,915 - $87,431
-1,186 Reduced 28.29%
3,007 $220,000
Q4 2021

Jan 19, 2022

BUY
$53.63 - $62.52 $37,433 - $43,638
698 Added 19.97%
4,193 $261,000
Q2 2021

Aug 09, 2021

SELL
$61.91 - $67.42 $53,242 - $57,981
-860 Reduced 19.75%
3,495 $234,000
Q1 2021

May 13, 2021

BUY
$59.34 - $66.74 $5,934 - $6,673
100 Added 2.35%
4,355 $275,000
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $97,638 - $110,642
-1,691 Reduced 28.44%
4,255 $264,000
Q3 2020

Nov 09, 2020

BUY
$57.43 - $63.64 $3,445 - $3,818
60 Added 1.02%
5,946 $358,000
Q2 2020

Aug 11, 2020

BUY
$54.82 - $64.09 $86,505 - $101,134
1,578 Added 36.63%
5,886 $346,000
Q1 2020

May 08, 2020

BUY
$46.4 - $67.43 $9,140 - $13,283
197 Added 4.79%
4,308 $240,000
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $202,302 - $263,885
4,111 New
4,111 $264,000
Q3 2019

Nov 12, 2019

SELL
$42.77 - $50.71 $246,611 - $292,393
-5,766 Closed
0 $0
Q2 2019

Jul 25, 2019

BUY
$44.62 - $49.34 $40,782 - $45,096
914 Added 18.84%
5,766 $261,000
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $26,846 - $32,011
-595 Reduced 10.92%
4,852 $231,000
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $265,595 - $344,413
5,447 New
5,447 $283,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Edge Capital Group, LLC Portfolio

Follow Edge Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Capital Group, LLC with notifications on news.